Ashmita Sapkota

Ashmita Sapkota

Auto-generated profile, based on publicly available information

Ashmita Sapkota

School of Health & Allied Sciences, Pokhara University, Kaski, Nepal

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
NSNandeeta Samad
Nandeeta Samad
SDSiddhartha Dutta
Siddhartha Dutta
TSTemitayo Eniola Sodunke
Temitayo Eniola Sodunke
AFAdiba Fairuz
Adiba Fairuz
ASAshmita Sapkota
Ashmita Sapkota
MHMainul Haque
Mainul Haque
The outbreak of pneumonia caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), later named COVID-19 by the World Health Organization (WHO), was initiated at Wuhan, Hubei, China, and there was a rapid spread of novel SARS-CoV-2 and the disease COVID-19 in late 2019. The entire world is now experiencing the challenge of COVID-19 infection. However, still very few evidence-based treatment options are available for the prevention and treatment of COVID-19 disease. The present review aims to summarize the publicly available information to give a comprehensive yet balanced scientific overview of all the fat-soluble vitamins concerning their role in SARS-CoV-2 virus infection. The roles of different fat-soluble vitamins and micronutrients in combating SARS-CoV-2 infection have been recently explored in several studies. There are various hypotheses to suggest their use to minimize the severity of COVID-19 infection. These vitamins are pivotal in the maintenance and modulation of innate and cell-mediated, and antibody-mediated immune responses. The data reported in recent literature demonstrate that deficiency in one or more of these vitamins compromises the patients’ immune response and makes them more vulnerable to viral infections and perhaps worse disease prognosis. Vitamins A, D, E, and K boost the body’s defense mechanism against COVID-19 infection and specifically prevent its complications such as cytokine storm and other inflammatory processes, leading to increased morbidity and mortality overemphasis. However, more detailed randomized double-blind clinical pieces of evidence are required to define the use of these supplements in preventing or reducing the severity of the COVID-19 infection.

1 November 2020 in Risk Management and Healthcare Policy
Verified
Journal Article
Open access
PDF file
NSNandeeta Samad
Nandeeta Samad
TSTemitayo Eniola Sodunke
Temitayo Eniola Sodunke
HBHasan Al Banna
Hasan Al Banna
ASAshmita Sapkota
Ashmita Sapkota
AFAneeka Nawar Fatema
Aneeka Nawar Fatema
MHMainul Haque
Mainul Haque
The world is striving against the severe crisis of the COVID-19 pandemic. Healthcare professionals are struggling to treat their patients based on nonspecific therapies. Amidst this uncertainty, convalescent plasma therapy (CPT) has appeared to be an interim adjuvant therapy for severely ill patients of COVID-19 until long-term clinical trial treatment options are available. Considering the transfusion-related hazards, especially lung injuries and microbial transmission, where sensitivity is not ensured, rigorous trials should be conducted to determine this therapy’s efficacy. Moreover, the ratio of recovered cases to plasma donors is not satisfying, which questioning this therapy’s availability and accessibility. Although some countries are making the treatment free, the attributable cost mandates a justification for its suitability and sustainability. Our article aimed to review the published facts and findings of CPT’s effectiveness in lowering the mortality rate of COVID-19. This pandemic showed that healthcare systems worldwide need core reform. A unified global collaboration must align and coordinate to face the current pandemic and enhance world readiness for future outbreaks based on health equity and equality.

1 December 2025 in International Medical Case Reports Journal
Verified
Journal Article
Open access
RBRajshree Bhujel
Rajshree Bhujel
NTNiraj Thapa
Niraj Thapa
RSRajani Shrestha
Rajani Shrestha
PPPrashant Pandit
Prashant Pandit
ASAshmita Sapkota
Ashmita Sapkota
NNNiranjan Nayak
Niranjan Nayak
Aspergillus species are relatively rare and typically occur in immune compromised individuals such as those undergoing organ transplantation, chemotherapy, or long-term corticosteroid therapy. Renal Aspergillosis is an uncommon manifestation that generally occurs as part of a disseminated infection in immunocompromised patients. A 22 yrs male patient came to emergency department of Manipal Teaching Hospital with the chief complaints of right flank pain, 3–4 episodes of vomiting for last 4 days, had acute onset, gradually progressive non-radiating aggravated pain and no history of any other medical conditions. His urine sample showed plenty of red blood cell in routine microscopy and other blood laboratory tests were within normal limit. Computed tomography of the kidneys, ureter and bladder showed multiple bilateral stones in both kidneys. Kidney stones were surgically removed by bilateral retrograde intrarenal surgery with total lithotripsy. After surgery, the renal calculi were received in microbiology laboratory for microbial analysis. The crushed material of renal stone was used for microbial culture and direct microscopy using 10% KOH wet mount which showed hyphae. Both bacterial culture media and Sabouraud’s Dextrose Agar showed growth of molds which was identified as Aspergillus fumigatius. The patient was treated with voriconazole intravenously with the loading dose of 6mg/Kg IV 12 hourly for 2 days followed by 4mg/Kg 12 hourly for 7 days. After 7 days of treatment, patient recovered well. Post-operative follow-up and post-operative radiography did not show evidence of any recurrence. This rare case of fungal etiology in patient having renal stones reveals the importance of closely monitoring postoperative patients, even when typical infection risk factors are absent.

1 January 2024 in Medical Laboratory Journal
Verified
Journal Article
Open access
PDF file
SJSuresh Jaiswal
Suresh Jaiswal
BSBijay Subedi
Bijay Subedi
ASAshmita Sapkota
Ashmita Sapkota
PSPushpa Sharma
Pushpa Sharma
MTManisha Timilsina
Manisha Timilsina
BTBishnu Raj Tiwari
Bishnu Raj Tiwari
Background: Intestinal infections with Helicobacter pylori mainly occur during childhood. If contracted, these infections may cause chronic gastritis, frequently leading to peptic ulcer disease in later life. This study aims to detect the prevalence of H. pylori infections in patients with active gastritis. Methods: The study included 150 participants who ...